Induced pluripotent stem cell technology is a promising, rapidly evolving field with the potential to transform cell-based therapeutics across a range of disease areas that have significant unmet medical needs. Read our recent article published in Nature's Biopharma Dealmakers to learn more about how Evotec accelerates off-the-shelf cell therapies for inflammatory and autoimmune diseases. 

^{If a preview of the pdf has not loaded above, please click here.}